{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:43:07Z","timestamp":1758044587025,"version":"3.44.0"},"reference-count":257,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780128190593"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/b978-0-12-819059-3.00017-4","type":"book-chapter","created":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T04:56:26Z","timestamp":1579236986000},"page":"417-450","source":"Crossref","is-referenced-by-count":2,"title":["New horizons on pH regulators as cancer biomarkers and targets for pharmacological intervention"],"prefix":"10.1016","author":[{"given":"F\u00e1tima","family":"Baltazar","sequence":"first","affiliation":[]},{"given":"Diana","family":"Valente","sequence":"additional","affiliation":[]},{"given":"Julieta","family":"Afonso","sequence":"additional","affiliation":[]},{"given":"Od\u00edlia","family":"Queir\u00f3s","sequence":"additional","affiliation":[]},{"given":"Sara","family":"Granja","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0010","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"3191","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semcancer.2016.12.003","article-title":"Value of pH regulators in the diagnosis, prognosis and treatment of cancer","volume":"43","author":"Granja","year":"2017","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10863-012-9428-1","article-title":"Role of monocarboxylate transporters in human cancers: state of the art","volume":"44","author":"Pinheiro","year":"2012","journal-title":"J Bioenerg Biomembr"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/metabo8010019","article-title":"Carbonic anhydrases: role in pH control and cancer","volume":"8","author":"Mboge","year":"2018","journal-title":"Metabolites"},{"issue":"2-3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0035","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.mam.2012.05.001","article-title":"SLC9\/NHE gene family, a plasma membrane and organellar family of Na(+)\/H(+) exchangers","volume":"34","author":"Donowitz","year":"2013","journal-title":"Mol Asp Med"},{"issue":"3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0040","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1152\/physrev.00035.2015","article-title":"The function of V-ATPases in cancer","volume":"96","author":"Stransky","year":"2016","journal-title":"Physiol Rev"},{"issue":"Pt 15","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0045","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1242\/jcs.088716","article-title":"P-type ATPases at a glance","volume":"124","author":"Bublitz","year":"2011","journal-title":"J Cell Sci"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0050","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fphys.2015.00166","article-title":"Regulators of Slc4 bicarbonate transporter activity","volume":"6","author":"Thornell","year":"2015","journal-title":"Front Physiol"},{"issue":"2-3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mam.2012.05.003","article-title":"The SLC16 gene family\u2014structure, role and regulation in health and disease","volume":"34","author":"Halestrap","year":"2013","journal-title":"Mol Asp Med"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/iub.573","article-title":"The monocarboxylate transporter family\u2014structure and functional characterization","volume":"64","author":"Halestrap","year":"2012","journal-title":"IUBMB Life"},{"issue":"Pt 2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj3430281","article-title":"The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation","volume":"343","author":"Halestrap","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/B978-0-12-394316-3.00009-0","article-title":"The SLC16A family of monocarboxylate transporters (MCTs)\u2014physiology and function in cellular metabolism, pH homeostasis, and fluid transport","volume":"70","author":"Adijanto","year":"2012","journal-title":"Curr Top Membr"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0075","first-page":"119","article-title":"Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect","volume":"38","author":"San-Millan","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0080","series-title":"Frontiers in anti-cancer drug discovery","first-page":"3","article-title":"Targeting metabolic reprogramming as an anti- cancer strategy: aiming at monocarboxylate transporters","volume":"vol. 6","author":"Pinheiro","year":"2016"},{"issue":"9","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0085","doi-asserted-by":"crossref","first-page":"6708","DOI":"10.18632\/oncotarget.2862","article-title":"Disruption of BASIGIN decreases lactic acid export and sensitizes non-small cell lung cancer to biguanides independently of the LKB1 status","volume":"6","author":"Granja","year":"2015","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0090","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1365-2559.2010.03560.x","article-title":"Monocarboxylate transporter 1 is up-regulated in basal-like breast carcinoma","volume":"56","author":"Pinheiro","year":"2010","journal-title":"Histopathology"},{"issue":"14","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0095","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1080\/15384101.2016.1188239","article-title":"Prognostic significance of monocarboxylate transporter expression in oral cavity tumors","volume":"15","author":"Simoes-Sousa","year":"2016","journal-title":"Cell Cycle (Georgetown, TX)"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.humpath.2014.09.013","article-title":"Expression of lactate\/H(+) symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses","volume":"46","author":"Kim","year":"2015","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/neuonc\/nos298","article-title":"Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets","volume":"15","author":"Miranda-Goncalves","year":"2013","journal-title":"Neuro-Oncology"},{"issue":"42","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0110","doi-asserted-by":"crossref","first-page":"44403","DOI":"10.18632\/oncotarget.5623","article-title":"Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors","volume":"6","author":"Pinheiro","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1476-4598-11-76","article-title":"Importance of glycolysis and oxidative phosphorylation in advanced melanoma","volume":"11","author":"Ho","year":"2012","journal-title":"Mol Cancer"},{"issue":"10","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0120","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1136\/gut.2009.181412","article-title":"CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models","volume":"58","author":"Schneiderhan","year":"2009","journal-title":"Gut"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00428-007-0558-5","article-title":"Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas","volume":"452","author":"Pinheiro","year":"2008","journal-title":"Virchows Arch"},{"issue":"8","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0130","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10585-010-9345-9","article-title":"Co-expression of CD147\/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression","volume":"27","author":"Chen","year":"2010","journal-title":"Clin Exp Metastasis"},{"issue":"4","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0135","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/PGP.0b013e31817b5b40","article-title":"Increasing expression of monocarboxylate transporters 1 and 4 along progression to invasive cervical carcinoma","volume":"27","author":"Pinheiro","year":"2008","journal-title":"Int J Gynecol Pathol"},{"issue":"29","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0140","doi-asserted-by":"crossref","first-page":"20386","DOI":"10.18632\/oncotarget.24910","article-title":"The clinicopathological significance of monocarboxylate transporters in testicular germ cell tumors","volume":"9","author":"Silva","year":"2018","journal-title":"Oncotarget"},{"issue":"33","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0145","doi-asserted-by":"crossref","first-page":"11780","DOI":"10.3748\/wjg.v20.i33.11780","article-title":"Characterization of monocarboxylate transporter activity in hepatocellular carcinoma","volume":"20","author":"Alves","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0150","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/1471-2407-11-312","article-title":"Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer","volume":"11","author":"Pertega-Gomes","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0155","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s13402-019-00426-2","article-title":"Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma\u2014MCT1 as potential target in diffuse large B cell lymphoma","volume":"42","author":"Afonso","year":"2019","journal-title":"Cell Oncol (Dordr)"},{"issue":"6","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0160","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.urolonc.2018.03.014","article-title":"Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis","volume":"36","author":"Cao","year":"2018","journal-title":"Urol Oncol"},{"issue":"11","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0165","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1080\/15384101.2016.1175258","article-title":"The metabolic microenvironment of melanomas: prognostic value of MCT1 and MCT4","volume":"15","author":"Pinheiro","year":"2016","journal-title":"Cell Cycle (Georgetown, TX)"},{"issue":"5","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0170","first-page":"2906","article-title":"Prognostic value of monocarboxylate transporter 4 in patients with esophageal squamous cell carcinoma","volume":"40","author":"Cheng","year":"2018","journal-title":"Oncol Rep"},{"issue":"12","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0175","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1158\/1535-7163.MCT-18-0107","article-title":"Selective inhibition of the lactate transporter MCT4 reduces growth of invasive bladder cancer","volume":"17","author":"Todenhofer","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0180","doi-asserted-by":"crossref","first-page":"242437","DOI":"10.1155\/2015\/242437","article-title":"Prognostic indications of elevated MCT4 and CD147 across cancer types: a meta-analysis","volume":"2015","author":"Bovenzi","year":"2015","journal-title":"Biomed Res Int"},{"issue":"40","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0185","doi-asserted-by":"crossref","first-page":"16663","DOI":"10.1073\/pnas.1106123108","article-title":"CD147 subunit of lactate\/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors","volume":"108","author":"Le Floch","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0190","doi-asserted-by":"crossref","first-page":"19177","DOI":"10.18632\/oncotarget.3910","article-title":"Targeting lactate transport suppresses in vivo breast tumor growth","volume":"6","author":"Morais-Santos","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0195","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2407-14-154","article-title":"Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression","volume":"14","author":"Sanita","year":"2014","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0200","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.celrep.2014.11.025","article-title":"MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies","volume":"9","author":"Baek","year":"2014","journal-title":"Cell Rep"},{"issue":"11","key":"10.1016\/B978-0-12-819059-3.00017-4_bb9256","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1158\/1078-0432.CCR-15-1624","article-title":"The MCT4 gene: a novel, potential target for therapy of advanced prostate cancer","volume":"22","author":"Choi","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0205","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/ijc.26125","article-title":"In vivo pH in metabolic-defective Ras-transformed fibroblast tumors: key role of the monocarboxylate transporter, MCT4, for inducing an alkaline intracellular pH","volume":"130","author":"Chiche","year":"2012","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0210","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1349-7006.2011.01908.x","article-title":"Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells","volume":"102","author":"Izumi","year":"2011","journal-title":"Cancer Sci"},{"issue":"12","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0215","first-page":"3930","article-title":"Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice","volume":"118","author":"Sonveaux","year":"2008","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0220","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1593\/neo.11134","article-title":"Metabolic targeting of lactate efflux by malignant glioma inhibits invasiveness and induces necrosis: an in vivo study","volume":"13","author":"Colen","year":"2011","journal-title":"Neoplasia (New York)"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0225","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.bbrc.2017.10.025","article-title":"Identification of a selective inhibitor of human monocarboxylate transporter 4","volume":"495","author":"Futagi","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0230","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/01.tp.0000287543.91765.41","article-title":"The specific monocarboxylate transporter (MCT1) inhibitor, AR-C117977, a novel immunosuppressant, prolongs allograft survival in the mouse","volume":"84","author":"Bueno","year":"2007","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0235","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/BJ20091515","article-title":"AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10","volume":"425","author":"Ovens","year":"2010","journal-title":"Biochem J"},{"issue":"4","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0240","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1158\/1078-0432.CCR-13-2270","article-title":"Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer","volume":"20","author":"Polanski","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0245","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1158\/1535-7163.MCT-13-1091","article-title":"Inhibition of monocarboxylate transporter-1 (MCT1) by AZD3965 enhances radiosensitivity by reducing lactate transport","volume":"13","author":"Bola","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"41","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0250","doi-asserted-by":"crossref","first-page":"69219","DOI":"10.18632\/oncotarget.18215","article-title":"Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity","volume":"8","author":"Curtis","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0255","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00109-015-1307-x","article-title":"Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate\/H symporters","volume":"94","author":"Marchiq","year":"2015","journal-title":"J Mol Med (Berl)"},{"issue":"11","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0260","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/j.celrep.2018.11.043","article-title":"Dual inhibition of the lactate transporters MCT1 and MCT4 is synthetic lethal with metformin due to NAD+ depletion in cancer cells","volume":"25","author":"Benjamin","year":"2018","journal-title":"Cell Rep"},{"issue":"15_suppl","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0265","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1200\/JCO.2017.35.15_suppl.2516","article-title":"A first-in-human first-in-class (FIC) trial of the monocarboxylate transporter 1 (MCT1) inhibitor AZD3965 in patients with advanced solid tumors","volume":"35","author":"Halford","year":"2017","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0270","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1113\/JP273309","article-title":"Hypoxia and cellular metabolism in tumor pathophysiology","volume":"595","author":"Parks","year":"2017","journal-title":"J Physiol"},{"issue":"6","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0275","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/med.21497","article-title":"Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one","volume":"38","author":"Supuran","year":"2018","journal-title":"Med Res Rev"},{"issue":"7","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0280","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2174\/138161208783877884","article-title":"Carbonic anhydrases\u2014an overview","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr Pharm Des"},{"issue":"12","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0285","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/13543784.2018.1548608","article-title":"Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors","volume":"27","author":"Supuran","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"issue":"3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0290","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0002-9440(10)64048-5","article-title":"Expression of the hypoxia-inducible and tumor- associated carbonic anhydrases in ductal carcinoma in situ of the breast","volume":"158","author":"Wykoff","year":"2001","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0295","first-page":"1279","article-title":"GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression","volume":"26","author":"Pinheiro","year":"2011","journal-title":"Histol Histopathol"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0300","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9440(10)64762-1","article-title":"Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors","volume":"156","author":"Kivela","year":"2000","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0305","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0002-9440(10)65569-1","article-title":"Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN\/CA IX, with potential value as a marker of cell proliferation","volume":"153","author":"Saarnio","year":"1998","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0310","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1515\/cclm-2014-0129","article-title":"Increased expression of carbonic anhydrase IX in oral submucous fibrosis and oral squamous cell carcinoma","volume":"52","author":"Yang","year":"2014","journal-title":"Clin Chem Lab Med"},{"issue":"11","key":"10.1016\/B978-0-12-819059-3.00017-4_bb9157","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/sj.bjc.6605690","article-title":"High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer","volume":"102","author":"Ilie","year":"2010","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0320","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/1568009616666151222150543","article-title":"Lactate transporters and pH regulation: potential therapeutic targets in glioblastomas","volume":"16","author":"Miranda-Goncalves","year":"2016","journal-title":"Curr Cancer Drug Targets"},{"issue":"4","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0325","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.eururo.2015.06.015","article-title":"Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer","volume":"68","author":"de Martino","year":"2015","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0330","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2559.2006.02523.x","article-title":"Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumors","volume":"49","author":"Hynninen","year":"2006","journal-title":"Histopathology"},{"issue":"24","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0335","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0340","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/sj.bjc.6603530","article-title":"Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer","volume":"96","author":"Hussain","year":"2007","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0345","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s12253-017-0284-5","article-title":"Overexpression of FZD1 and CAIX are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma","volume":"24","author":"Yang","year":"2018","journal-title":"Pathol Oncol Res"},{"issue":"7","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200855","article-title":"Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis","volume":"13","author":"Finkelmeier","year":"2018","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114096","article-title":"Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0360","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.advenzreg.2009.10.005","article-title":"Membrane-bound carbonic anhydrases are key pH regulators controlling tumor growth and cell migration","volume":"50","author":"Chiche","year":"2010","journal-title":"Adv Enzym Regul"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0365","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-94-007-7359-2_12","article-title":"Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases","volume":"75","author":"Tafreshi","year":"2014","journal-title":"Subcell Biochem"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0370","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1471-2407-9-246","article-title":"Carbonic anhydrase 9 is a predictive marker of survival benefit from lower dose of bevacizumab in patients with previously treated metastatic colorectal cancer","volume":"9","author":"Hong","year":"2009","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0375","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1464-410X.2010.09218.x","article-title":"Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy","volume":"106","author":"Choueiri","year":"2010","journal-title":"BJU Int"},{"issue":"12","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0380","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1177\/002215540004801203","article-title":"Expression of the membrane-associated carbonic anhydrase isozyme XII in the human kidney and renal tumors","volume":"48","author":"Parkkila","year":"2000","journal-title":"J Histochem Cytochem"},{"issue":"7","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0385","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/ijc.25491","article-title":"Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis","volume":"128","author":"Ilie","year":"2011","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0390","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s004180000181","article-title":"Expression of transmembrane carbonic anhydrase isoenzymes IX and XII in normal human pancreas and pancreatic tumors","volume":"114","author":"Kivela","year":"2000","journal-title":"Histochem Cell Biol"},{"issue":"3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033952","article-title":"CAXII Is a sero-diagnostic marker for lung cancer","volume":"7","author":"Kobayashi","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0400","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1748-717X-5-101","article-title":"Carbonic anhydrase XII expression is associated with histologic grade of cervical cancer and superior radiotherapy outcome","volume":"5","author":"Yoo","year":"2010","journal-title":"Radiat Oncol (Lond)"},{"issue":"5","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0405","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.oraloncology.2011.11.015","article-title":"Tumor-associated carbonic anhydrase XII is linked to the growth of primary oral squamous cell carcinoma and its poor prognosis","volume":"48","author":"Chien","year":"2012","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0410","doi-asserted-by":"crossref","DOI":"10.3390\/metabo8010002","article-title":"Rethinking the combination of proton exchanger inhibitors in cancer therapy","volume":"8","author":"Iessi","year":"2017","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0415","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0420","first-page":"199","article-title":"Knock-down of hypoxia-induced carbonic anhydrases IX and XII radiosensitizes tumor cells by increasing intracellular acidosis","volume":"2","author":"Doyen","year":"2012","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0425","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0430","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.neo.2015.05.001","article-title":"In vivo loss of function screening reveals carbonic anhydrase IX as a key modulator of tumor initiating potential in primary pancreatic tumors","volume":"17","author":"Pore","year":"2015","journal-title":"Neoplasia (New York)"},{"issue":"16","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0435","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1016\/j.bmcl.2009.06.022","article-title":"In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives","volume":"19","author":"Ahlskog","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"issue":"11","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0440","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1021\/jm300529u","article-title":"Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts","volume":"55","author":"Gieling","year":"2012","journal-title":"J Med Chem"},{"issue":"44","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0445","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1038\/onc.2012.550","article-title":"Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche","volume":"32","author":"Lock","year":"2013","journal-title":"Oncogene"},{"issue":"24","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0450","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92928","article-title":"Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo","volume":"2","author":"Boyd","year":"2017","journal-title":"JCI Insight"},{"issue":"29","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0455","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.2174\/138161210793429832","article-title":"Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain","volume":"16","author":"Zatovicova","year":"2010","journal-title":"Curr Pharm Des"},{"issue":"21","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0460","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1158\/0008-5472.CAN-13-1110","article-title":"Antitumor efficacy of a monoclonal antibody that inhibits the activity of cancer-associated carbonic anhydrase XII","volume":"73","author":"Gondi","year":"2013","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0465","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00262-011-0980-z","article-title":"Generation and characterization of the first inhibitory antibody targeting tumor-associated carbonic anhydrase XII","volume":"60","author":"Battke","year":"2011","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0470","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1158\/1535-7163.MCT-11-0523","article-title":"Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9","volume":"11","author":"Petrul","year":"2012","journal-title":"Mol Cancer Ther"},{"issue":"15","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0475","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1016\/j.bmcl.2009.06.002","article-title":"The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian alpha-carbonic anhydrase isoforms","volume":"19","author":"Parkkila","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0480","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ijc.2910380406","article-title":"Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney","volume":"38","author":"Oosterwijk","year":"1986","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0485","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.3390\/ijms140611402","article-title":"Application of monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinoma","volume":"14","author":"Oosterwijk-Wakka","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0490","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00345-010-0570-2","article-title":"A clinical phase I\/II trial with the monoclonal antibody cG250 (RENCAREX(R)) and interferon-alpha-2a in metastatic renal cell carcinoma patients","volume":"29","author":"Siebels","year":"2011","journal-title":"World J Urol"},{"issue":"31 Suppl","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0495","article-title":"ARISER: a randomized double blind phase III study to evaluate adjuvant cG250 treatment versus placebo in patients with high-risk ccRCC\u2014results and implications for adjuvant clinical trials","volume":"31","author":"Belldegrun","year":"2013","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0500","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00262-002-0268-4","article-title":"Anti-renal cell carcinoma chimeric antibody G250: cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity","volume":"51","author":"Liu","year":"2002","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb9257","first-page":"391","article-title":"Sodium-proton (Na+\/H+) antiporters: properties and roles in health and disease","volume":"16","author":"Padan","year":"2016","journal-title":"Met Ions Life Sci"},{"issue":"5","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0505","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00424-003-1110-3","article-title":"Diversity of the mammalian sodium\/proton exchanger SLC9 gene family","volume":"447","author":"Orlowski","year":"2004","journal-title":"Pflugers Arch"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0510","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2174\/1574892811308010085","article-title":"Na+-H+ exchanger, pH regulation and cancer","volume":"8","author":"Reshkin","year":"2013","journal-title":"Recent Pat Anticancer Drug Discov"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0515","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbrc.2017.03.007","article-title":"Elevated Na(+)\/H(+) exchanger-1 expression enhances the metastatic collective migration of head and neck squamous cell carcinoma cells","volume":"486","author":"Kaminota","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"14","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0520","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1096\/fj.00-0029com","article-title":"Na+\/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes","volume":"14","author":"Reshkin","year":"2000","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0525","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/jcp.21277","article-title":"EGF upregulates Na+\/H+ exchanger NHE1 by post-translational regulation that is important for cervical cancer cell invasiveness","volume":"214","author":"Chiang","year":"2008","journal-title":"J Cell Physiol"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0530","doi-asserted-by":"crossref","first-page":"115","DOI":"10.15171\/bi.2017.15","article-title":"Molecular machineries of pH dysregulation in tumor microenvironment: potential targets for cancer therapy","volume":"7","author":"Asgharzadeh","year":"2017","journal-title":"Bioimpacts"},{"issue":"4","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0535","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1158\/0008-5472.CAN-12-4031","article-title":"Regulation of the Na+\/H+ exchanger (NHE1) in breast cancer metastasis","volume":"73","author":"Amith","year":"2013","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0540","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1074\/jbc.275.8.5361","article-title":"Phosphoinositide 3-kinase is involved in the tumor-specific activation of human breast cancer cell Na(+)\/H(+) exchange, motility, and invasion induced by serum deprivation","volume":"275","author":"Reshkin","year":"2000","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0545","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3892\/ijo.2013.2158","article-title":"Extracellular matrix composition and interstitial pH modulate NHE1-mediated melanoma cell motility","volume":"44","author":"Vahle","year":"2014","journal-title":"Int J Oncol"},{"issue":"10","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0550","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrc1713","article-title":"The role of disturbed pH dynamics and the Na+\/H+ exchanger in metastasis","volume":"5","author":"Cardone","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0555","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00249-008-0385-x","article-title":"On the relationship between drug's size, cell membrane mechanical properties and high levels of multi drug resistance: a comparison to published data","volume":"38","author":"Rauch","year":"2009","journal-title":"Eur Biophys J"},{"issue":"3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0560","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0306-9877(92)90114-R","article-title":"The Na+\/H+ antiporter in oncology in the light of the spontaneous regression of cancer and cell metabolism","volume":"39","author":"Harguindey","year":"1992","journal-title":"Med Hypotheses"},{"issue":"4","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0565","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s12032-009-9343-4","article-title":"Over-expression of Na+\/H+ exchanger 1 and its clinicopathologic significance in hepatocellular carcinoma","volume":"27","author":"Yang","year":"2010","journal-title":"Med Oncol"},{"issue":"9","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0570","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/carcin\/bgu089","article-title":"Upregulation of NHE1 protein expression enables glioblastoma cells to escape TMZ-mediated toxicity via increased H(+) extrusion, cell migration and survival","volume":"35","author":"Cong","year":"2014","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0575","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbadis.2016.10.013","article-title":"Sodium\/proton exchanger isoform 1 regulates intracellular pH and cell proliferation in human ovarian cancer","volume":"1863","author":"Sanhueza","year":"2017","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0580","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.18632\/oncotarget.13645","article-title":"Na+\/H+ exchanger 1 has tumor suppressive activity and prognostic value in esophageal squamous cell carcinoma","volume":"8","author":"Ariyoshi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0585","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/1479-5876-11-282","article-title":"Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs\u2014an integral molecular\/biochemical\/metabolic\/clinical approach after one hundred years of cancer research","volume":"11","author":"Harguindey","year":"2013","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0590","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1593\/neo.08178","article-title":"Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles","volume":"10","author":"Giusti","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0595","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2010.09.059","article-title":"Dual inhibition of sodium-mediated proton and calcium efflux triggers non-apoptotic cell death in malignant gliomas","volume":"1363","author":"Harley","year":"2010","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0600","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2010.03.001","article-title":"Inhibition of Na(+)\/H(+) exchanger 1 by 5-(N-ethyl-N-isopropyl) amiloride reduces hypoxia-induced hepatocellular carcinoma invasion and motility","volume":"295","author":"Yang","year":"2010","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0605","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/sj.bjc.6600424","article-title":"Cytostatic potential of novel agents that inhibit the regulation of intracellular pH","volume":"87","author":"Wong","year":"2002","journal-title":"Br J Cancer"},{"issue":"21","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0610","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1158\/1078-0432.CCR-17-0678","article-title":"Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma","volume":"23","author":"Rojas","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb9258","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11515-014-1289-z","article-title":"Amiloride and guggulsterone suppression of esophageal cancer cell growth in vitro and in nude mouse xenografts","volume":"9","author":"Guan","year":"2014","journal-title":"Front Biol (Beijing)"},{"issue":"4","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0615","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1182\/blood.V95.4.1427.004k48_1427_1434","article-title":"Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na(+)\/H(+) exchanger","volume":"95","author":"Rich","year":"2000","journal-title":"Blood"},{"issue":"9","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0620","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/ijc.26156","article-title":"Anti-tumor\/metastasis effects of the potassium-sparing diuretic amiloride: an orally active anti-cancer drug waiting for its call-of-duty?","volume":"129","author":"Matthews","year":"2011","journal-title":"Int J Cancer"},{"issue":"2-3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0625","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0378-4274(99)00072-7","article-title":"Na+ :H+ exchange inhibition induces intracellular acidosis and differentially impairs cell growth and viability of human and rat hepatocarcinoma cells","volume":"106","author":"Garcia-Canero","year":"1999","journal-title":"Toxicol Lett"},{"issue":"3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0630","first-page":"488","article-title":"Effect of the NHE-1-specific inhibitor DMA on pHi, proliferation and apoptosis of HL-60\/ADM cells in vitro","volume":"14","author":"Chang","year":"2006","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"6","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0635","first-page":"2366","article-title":"Paclitaxel induces apoptosis via protein kinase A- and p38 mitogen-activated protein-dependent inhibition of the Na+\/H+ exchanger (NHE) NHE isoform 1 in human breast cancer cells","volume":"9","author":"Reshkin","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0640","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yjmcc.2013.02.006","article-title":"NHE-1: still a viable therapeutic target","volume":"61","author":"Karmazyn","year":"2013","journal-title":"J Mol Cell Cardiol"},{"issue":"10","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0645","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.ijom.2012.03.001","article-title":"Blocking the Na+\/H+ exchanger 1 with cariporide (HOE642) reduces the hypoxia-induced invasion of human tongue squamous cell carcinoma","volume":"41","author":"Lv","year":"2012","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"5","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0650","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s10147-018-1289-0","article-title":"In vivo detection of acute intracellular acidification in glioblastoma multiforme following a single dose of cariporide","volume":"23","author":"Albatany","year":"2018","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0655","first-page":"341","article-title":"Rapid decrease of intracellular pH associated with inhibition of Na+\/H+ exchanger precedes apoptotic events in the MNK45 and MNK74 gastric cancer cell lines treated with 2-aminophenoxazine-3-one","volume":"25","author":"Nagata","year":"2011","journal-title":"Oncol Rep"},{"issue":"4","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0660","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2183\/pjab.87.199","article-title":"2-Aminophenoxazine-3-one and 2-amino-4,4alpha-dihydro-4alpha,7-dimethyl-3H-phenoxazine-3-one cause cellular apoptosis by reducing higher intracellular pH in cancer cells","volume":"87","author":"Che","year":"2011","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"9","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0665","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1080\/15384101.2018.1464850","article-title":"The acid-base transport proteins NHE1 and NBCn1 regulate cell cycle progression in human breast cancer cells","volume":"17","author":"Flinck","year":"2018","journal-title":"Cell Cycle"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0670","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ultsonch.2017.05.013","article-title":"Combination of sonodynamic with temozolomide inhibits C6 glioma migration and promotes mitochondrial pathway apoptosis via suppressing NHE-1 expression","volume":"39","author":"Chen","year":"2017","journal-title":"Ultrason Sonochem"},{"issue":"25","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0675","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1161\/01.CIR.101.25.2902","article-title":"Cardioprotective effects of the Na(+)\/H(+) exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA","volume":"101","author":"Rupprecht","year":"2000","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0680","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.athoracsur.2007.10.054","article-title":"Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study","volume":"85","author":"Mentzer","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0685","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0735-1097(01)01608-4","article-title":"The Na(+)\/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial","volume":"38","author":"Zeymer","year":"2001","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0690","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.coph.2007.12.007","article-title":"Targeting Na+\/H+ exchanger regulation for cardiac protection: a RSKy approach?","volume":"8","author":"Avkiran","year":"2008","journal-title":"Curr Opin Pharmacol"},{"issue":"9","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0695","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrc3579","article-title":"Disrupting proton dynamics and energy metabolism for cancer therapy","volume":"13","author":"Parks","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0700","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1756-9966-29-44","article-title":"Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy","volume":"29","author":"Spugnini","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0705","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/09723757.2012.11886177","article-title":"ATP-ase as a potential drug target for cancer, tumor growth and cellular functions","volume":"12","author":"Sakthivel","year":"2012","journal-title":"Int J Hum Genet"},{"issue":"23","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0710","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1021\/bi100397s","article-title":"Regulation and isoform function of the V-ATPases","volume":"49","author":"Toei","year":"2010","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0715","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047900","article-title":"CaMKKbeta is involved in AMP-activated protein kinase activation by baicalin in LKB1 deficient cell lines","volume":"7","author":"Ma","year":"2012","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0720","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/MCB.25.2.575-589.2005","article-title":"Phosphatidylinositol 3-kinase-mediated effects of glucose on vacuolar H+-ATPase assembly, translocation, and acidification of intracellular compartments in renal epithelial cells","volume":"25","author":"Sautin","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"45","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0725","doi-asserted-by":"crossref","first-page":"27360","DOI":"10.1074\/jbc.M115.659128","article-title":"Amino acid availability modulates vacuolar H+-ATPase assembly","volume":"290","author":"Stransky","year":"2015","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0730","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1074\/jbc.M113.524561","article-title":"Regulated assembly of vacuolar ATPase is increased during cluster disruption-induced maturation of dendritic cells through a phosphatidylinositol 3-kinase\/mTOR-dependent pathway","volume":"289","author":"Liberman","year":"2014","journal-title":"J Biol Chem"},{"issue":"5611","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0735","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1126\/science.1080106","article-title":"Activation of lysosomal function during dendritic cell maturation","volume":"299","author":"Trombetta","year":"2003","journal-title":"Science"},{"issue":"4","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0740","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1462-5822.2010.01556.x","article-title":"Influenza A virus-induced early activation of ERK and PI3K mediates V-ATPase-dependent intracellular pH change required for fusion","volume":"13","author":"Marjuki","year":"2011","journal-title":"Cell Microbiol"},{"issue":"8","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0745","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.cellsig.2011.03.003","article-title":"Structural bases of physiological functions and roles of the vacuolar H(+)-ATPase","volume":"23","author":"Ma","year":"2011","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0750","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.00340.2006","article-title":"New insights into the regulation of V-ATPase-dependent proton secretion","volume":"292","author":"Breton","year":"2007","journal-title":"Am J Physiol Ren Physiol"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0755","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1385\/CBB:40:2:185","article-title":"Plasmalemmal vacuolar-type H+-ATPase in cancer biology","volume":"40","author":"Sennoune","year":"2004","journal-title":"Cell Biochem Biophys"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0760","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.abb.2008.03.025","article-title":"Function, structure and regulation of the vacuolar (H+)-ATPases","volume":"476","author":"Jefferies","year":"2008","journal-title":"Arch Biochem Biophys"},{"issue":"8","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0765","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1002\/cam4.1594","article-title":"Vacuolar ATPase as a potential therapeutic target and mediator of treatment resistance in cancer","volume":"7","author":"Whitton","year":"2018","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0770","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3892\/etm.2015.2758","article-title":"Bafilomycin A1 inhibits the growth and metastatic potential of the BEL-7402 liver cancer and HO-8910 ovarian cancer cell lines and induces alterations in their microRNA expression","volume":"10","author":"Lu","year":"2015","journal-title":"Exp Ther Med"},{"issue":"8","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0775","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ctrv.2009.08.003","article-title":"V-ATPase inhibitors and implication in cancer treatment","volume":"35","author":"Perez-Sayans","year":"2009","journal-title":"Cancer Treat Rev"},{"issue":"29","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0780","doi-asserted-by":"crossref","first-page":"46142","DOI":"10.18632\/oncotarget.10063","article-title":"The a3 isoform of subunit a of the vacuolar ATPase localizes to the plasma membrane of invasive breast tumor cells and is overexpressed in human breast cancer","volume":"7","author":"Cotter","year":"2016","journal-title":"Oncotarget"},{"issue":"24","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0785","doi-asserted-by":"crossref","first-page":"16400","DOI":"10.1074\/jbc.M901201200","article-title":"Function of a subunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells","volume":"284","author":"Hinton","year":"2009","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0790","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.oraloncology.2007.02.011","article-title":"Intracellular pH regulation in oral squamous cell carcinoma is mediated by increased V-ATPase activity via over-expression of the ATP6V1C1 gene","volume":"44","author":"Otero-Rey","year":"2008","journal-title":"Oral Oncol"},{"issue":"15","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0795","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.1158\/0008-5472.CAN-04-3822","article-title":"The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump","volume":"65","author":"Lu","year":"2005","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0800","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/labinvest.2011.8","article-title":"The vacuolar-ATPase modulates matrix metalloproteinase isoforms in human pancreatic cancer","volume":"91","author":"Chung","year":"2011","journal-title":"Lab Investig"},{"issue":"7","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0805","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/jcb.24106","article-title":"Silencing of a novel tumor metastasis suppressor gene LASS2\/TMSG1 promotes invasion of prostate cancer cell in vitro through increase of vacuolar ATPase activity","volume":"113","author":"Xu","year":"2012","journal-title":"J Cell Biochem"},{"issue":"31","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0810","doi-asserted-by":"crossref","first-page":"49334","DOI":"10.18632\/oncotarget.10340","article-title":"Prognostic significance and function of the vacuolar H+-ATPase subunit V1E1 in esophageal squamous cell carcinoma","volume":"7","author":"Son","year":"2016","journal-title":"Oncotarget"},{"issue":"19","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0815","doi-asserted-by":"crossref","first-page":"17514","DOI":"10.18632\/oncotarget.4239","article-title":"The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma","volume":"6","author":"Di Cristofori","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0820","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/10520295.2011.574647","article-title":"Immunohistochemical localization of C1 subunit of V-ATPase (ATPase C1) in oral squamous cell cancer and normal oral mucosa","volume":"87","author":"Garcia-Garcia","year":"2012","journal-title":"Biotech Histochem"},{"issue":"12","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0825","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1093\/carcin\/bgs277","article-title":"Expression and functional role of vacuolar H(+)-ATPase in human hepatocellular carcinoma","volume":"33","author":"Xu","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb0830","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1746-1596-8-145","article-title":"The expression of V-ATPase is associated with drug resistance and pathology of non-small-cell lung cancer","volume":"8","author":"Lu","year":"2013","journal-title":"Diagn Pathol"},{"issue":"6","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0835","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.18632\/oncotarget.2902","article-title":"Vacuolar ATPase \u2018a2' isoform exhibits distinct cell surface accumulation and modulates matrix metalloproteinase activity in ovarian cancer","volume":"6","author":"Kulshrestha","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0840","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1038\/s41598-017-03021-3","article-title":"Expression and transcriptional regulation of human ATP6V1A gene in gastric cancers","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"issue":"5-6","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0845","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10863-007-9108-8","article-title":"Plasmalemmal vacuolar H+-ATPases in angiogenesis, diabetes and cancer","volume":"39","author":"Sennoune","year":"2007","journal-title":"J Bioenerg Biomembr"},{"issue":"10","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0850","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.tibs.2015.08.005","article-title":"Recent insights into the structure, regulation, and function of the V-ATPases","volume":"40","author":"Cotter","year":"2015","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0855","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4143\/crt.2016.034","article-title":"Proton pump inhibition enhances the cytotoxicity of paclitaxel in cervical cancer","volume":"49","author":"Song","year":"2016","journal-title":"Cancer Res Treat"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0860","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/17474086.2018.1407239","article-title":"Vacuolar ATPase as a possible therapeutic target in human acute myeloid leukemia","volume":"11","author":"Aasebo","year":"2018","journal-title":"Expert Rev Hematol"},{"issue":"4","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0865","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10147-015-0782-y","article-title":"Expression and role of V1A subunit of V-ATPases in gastric cancer cells","volume":"20","author":"Liu","year":"2015","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0870","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbadis.2013.01.020","article-title":"The role of proton dynamics in the development and maintenance of multidrug resistance in cancer","volume":"1832","author":"Daniel","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0875","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0163-7258(99)00073-X","article-title":"Resistance mechanisms associated with altered intracellular distribution of anticancer agents","volume":"85","author":"Larsen","year":"2000","journal-title":"Pharmacol Ther"},{"issue":"10","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0880","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2174\/138161212799504821","article-title":"Intracellular proton pumps as targets in chemotherapy: V-ATPases and cancer","volume":"18","author":"Hernandez","year":"2012","journal-title":"Curr Pharm Des"},{"issue":"Pt 1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0885","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1242\/jeb.200.1.1","article-title":"Bafilomycins and concanamycins as inhibitors of V-ATPases and P-ATPases","volume":"200","author":"Drose","year":"1997","journal-title":"J Exp Biol"},{"issue":"48","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0890","doi-asserted-by":"crossref","first-page":"28921","DOI":"10.18632\/oncotarget.25641","article-title":"V-ATPase-dependent repression of androgen receptor in prostate cancer cells","volume":"9","author":"Licon-Munoz","year":"2018","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0895","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00383-008-2229-2","article-title":"The proton pump inhibitor inhibits cell growth and induces apoptosis in human hepatoblastoma","volume":"24","author":"Morimura","year":"2008","journal-title":"Pediatr Surg Int"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0900","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1074\/jbc.M112.412007","article-title":"Mode of cell death induction by pharmacological vacuolar H+-ATPase (V-ATPase) inhibition","volume":"288","author":"von Schwarzenberg","year":"2013","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0905","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/1535-7163.MCT-17-0129","article-title":"Inhibition of the V-ATPase by archazolid A: a new strategy to inhibit EMT","volume":"16","author":"Merk","year":"2017","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"10.1016\/B978-0-12-819059-3.00017-4_bb9261","doi-asserted-by":"crossref","first-page":"9476","DOI":"10.18632\/oncotarget.14339","article-title":"V-ATPase inhibition increases cancer cell stiffness and blocks membrane related Ras signaling\u2014a new option for HCC therapy","volume":"8","author":"Bartel","year":"2017","journal-title":"Oncotarget"},{"issue":"41","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0910","doi-asserted-by":"crossref","first-page":"43508","DOI":"10.18632\/oncotarget.6180","article-title":"Anti-leukemic effects of the V-ATPase inhibitor archazolid A","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0915","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1158\/0008-5472.CAN-12-1772","article-title":"The V-ATPase-inhibitor archazolid abrogates tumor metastasis via inhibition of endocytic activation of the Rho-GTPase Rac1","volume":"72","author":"Wiedmann","year":"2012","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0920","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/ijc.28562","article-title":"V-ATPase inhibition by archazolid leads to lysosomal dysfunction resulting in impaired cathepsin B activation in vivo","volume":"134","author":"Kubisch","year":"2014","journal-title":"Int J Cancer"},{"issue":"29","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0925","doi-asserted-by":"crossref","first-page":"10580","DOI":"10.1073\/pnas.1401591111","article-title":"An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore","volume":"111","author":"Alavian","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0930","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1158\/0008-5472.CAN-14-2097","article-title":"Vacuolar-ATPase inhibition blocks iron metabolism to mediate therapeutic effects in breast cancer","volume":"75","author":"Schneider","year":"2015","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0935","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molonc.2013.08.011","article-title":"V-ATPase inhibition overcomes trastuzumab resistance in breast cancer","volume":"8","author":"von Schwarzenberg","year":"2014","journal-title":"Mol Oncol"},{"issue":"6","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0940","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1158\/0008-5472.CAN-15-3545","article-title":"Bone pain induced by multiple myeloma is reduced by targeting V-ATPase and ASIC3","volume":"77","author":"Hiasa","year":"2017","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0945","doi-asserted-by":"crossref","first-page":"853","DOI":"10.7150\/ijbs.6030","article-title":"Silencing of atp6v1c1 prevents breast cancer growth and bone metastasis","volume":"9","author":"Feng","year":"2013","journal-title":"Int J Biol Sci"},{"issue":"7","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0950","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1158\/1541-7786.MCR-10-0449","article-title":"The a3 isoform vacuolar type H(+)-ATPase promotes distant metastasis in the mouse B16 melanoma cells","volume":"9","author":"Nishisho","year":"2011","journal-title":"Mol Cancer Res"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0955","first-page":"98","article-title":"Dyspepsia, peptic ulcer disease, and esophageal reflux disease","volume":"176","author":"Schwartz","year":"2002","journal-title":"West J Med"},{"issue":"22","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0960","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/jnci\/djh305","article-title":"Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs","volume":"96","author":"Luciani","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0965","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1517\/14656566.6.7.1049","article-title":"Proton pump inhibitors may reduce tumor resistance","volume":"6","author":"De Milito","year":"2005","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0970","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40272-013-0012-x","article-title":"Proton pump inhibitors in pediatrics: mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics","volume":"15","author":"Ward","year":"2013","journal-title":"Paediatr Drugs"},{"issue":"24","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0975","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.1158\/1078-0432.CCR-04-1065","article-title":"Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells","volume":"10","author":"Yeo","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0980","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ijc.25009","article-title":"pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity","volume":"127","author":"De Milito","year":"2010","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0985","doi-asserted-by":"crossref","first-page":"439","DOI":"10.18433\/J34608","article-title":"Use of proton pump inhibitors as adjunct treatment for triple-negative breast cancers. An introductory study","volume":"17","author":"Goh","year":"2014","journal-title":"J Pharm Pharm Sci"},{"issue":"33","key":"10.1016\/B978-0-12-819059-3.00017-4_bb9262","doi-asserted-by":"crossref","first-page":"35040","DOI":"10.18632\/oncotarget.5319","article-title":"Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0990","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.canlet.2010.03.019","article-title":"Multidrug resistance in oral squamous cell carcinoma: the role of vacuolar ATPases","volume":"295","author":"Perez-Sayans","year":"2010","journal-title":"Cancer Lett"},{"issue":"11","key":"10.1016\/B978-0-12-819059-3.00017-4_bb0995","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1158\/0008-5472.CAN-06-4095","article-title":"Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species","volume":"67","author":"De Milito","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb1000","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13046-014-0073-x","article-title":"Proton pump inhibitors (PPIs) impact on tumor cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miRNAs in esophageal cancer","volume":"33","author":"Lindner","year":"2014","journal-title":"J Exp Clin Cancer Res"},{"issue":"2 Pt B","key":"10.1016\/B978-0-12-819059-3.00017-4_bb9263","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.canlet.2014.10.017","article-title":"Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma","volume":"356","author":"Azzarito","year":"2015","journal-title":"Cancer Lett"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb1005","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.2147\/OTT.S161198","article-title":"Effects of proton pump inhibitors on reversing multidrug resistance via downregulating V-ATPases\/PI3K\/Akt\/mTOR\/HIF-1alpha signaling pathway through TSC1\/2 complex and Rheb in human gastric adenocarcinoma cells in vitro and in vivo","volume":"11","author":"Chen","year":"2018","journal-title":"Onco Targets Ther"},{"issue":"2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1010","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.fct.2007.09.106","article-title":"Biological effects of essential oils\u2014a review","volume":"46","author":"Bakkali","year":"2008","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1015","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00204-017-2146-z","article-title":"Combination of etoposide and fisetin results in anti-cancer efficiency against osteosarcoma cell models","volume":"92","author":"Ferreira de Oliveira","year":"2018","journal-title":"Arch Toxicol"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbagen.2018.09.006","article-title":"Myrtenal-induced V-ATPase inhibition\u2014a toxicity mechanism behind tumor cell death and suppressed migration and invasion in melanoma","volume":"1863","author":"Martins","year":"2019","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"4","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1025","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/pds.4702","article-title":"Proton pump inhibitor use and risk of breast cancer, prostate cancer, and malignant melanoma: an Icelandic population-based case-control study","volume":"28","author":"Halfdanarson","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb1030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fphys.2015.00355","article-title":"Structure and function of SLC4 family [formula: see text] transporters","volume":"6","author":"Liu","year":"2015","journal-title":"Front Physiol"},{"issue":"3 Pt 1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1035","first-page":"C247","article-title":"Proton-sulfate cotransport: external proton activation of sulfate influx into human red blood cells","volume":"247","author":"Milanick","year":"1984","journal-title":"Am J Phys"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1085\/jgp.107.1.145","article-title":"Characterization of oxalate transport by the human erythrocyte band 3 protein","volume":"107","author":"Jennings","year":"1996","journal-title":"J Gen Physiol"},{"issue":"Pt 11","key":"10.1016\/B978-0-12-819059-3.00017-4_bb9264","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1242\/jeb.029454","article-title":"Molecular physiology and genetics of Na+-independent SLC4 anion exchangers","volume":"212","author":"Alper","year":"2009","journal-title":"J Exp Biol"},{"issue":"9","key":"10.1016\/B978-0-12-819059-3.00017-4_bb9265","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1182\/blood.V96.9.2925","article-title":"Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3","volume":"96","author":"Zhang","year":"2000","journal-title":"Blood"},{"issue":"37","key":"10.1016\/B978-0-12-819059-3.00017-4_bb9266","doi-asserted-by":"crossref","first-page":"26372","DOI":"10.1074\/jbc.M113.465989","article-title":"Structural model of the anion exchanger 1 (SLC4A1) and identification of transmembrane segments forming the transport site","volume":"288","author":"Barneaud-Rocca","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb9267","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-94-007-7359-2_7","article-title":"Carbonic anhydrases and their interplay with acid\/base-coupled membrane transporters","volume":"75","author":"Becker","year":"2014","journal-title":"Subcell Biochem"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb9268","doi-asserted-by":"crossref","first-page":"F157","DOI":"10.1152\/ajprenal.00228.2010","article-title":"Glyceraldehyde 3-phosphate dehydrogenase is required for band 3 (anion exchanger 1) membrane residency in the mammalian kidney","volume":"300","author":"Su","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"issue":"28","key":"10.1016\/B978-0-12-819059-3.00017-4_bb9269","doi-asserted-by":"crossref","first-page":"25239","DOI":"10.1074\/jbc.M202562200","article-title":"The extracellular component of a transport metabolon. Extracellular loop 4 of the human AE1 Cl-\/HCO3-exchanger binds carbonic anhydrase IV","volume":"277","author":"Sterling","year":"2002","journal-title":"J Biol Chem"},{"issue":"2-3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.mam.2012.10.008","article-title":"The SLC4 family of bicarbonate (HCO(3)(-)) transporters","volume":"34","author":"Romero","year":"2013","journal-title":"Mol Asp Med"},{"issue":"6025","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1050","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/316234a0","article-title":"Primary structure and transmembrane orientation of the murine anion exchange protein","volume":"316","author":"Kopito","year":"1985","journal-title":"Nature"},{"issue":"23","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1055","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1073\/pnas.86.23.9089","article-title":"Cloning and characterization of band 3, the human erythrocyte anion- exchange protein (AE1)","volume":"86","author":"Lux","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6 Pt 2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1060","first-page":"F813","article-title":"Anion exchanger 1 in human kidney and oncocytoma differs from erythroid AE1 in its NH2 terminus","volume":"265","author":"Kollert-Jons","year":"1993","journal-title":"Am J Phys"},{"issue":"6","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1065","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2257.2001.00416.x","article-title":"Respiratory changes in human red cells","volume":"23","author":"Aliberti","year":"2001","journal-title":"Clin Lab Haematol"},{"issue":"15","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1070","doi-asserted-by":"crossref","first-page":"11283","DOI":"10.1016\/S0021-9258(18)82122-6","article-title":"The apical Cl\/HCO3 exchanger of beta intercalated cells","volume":"268","author":"van Adelsberg","year":"1993","journal-title":"J Biol Chem"},{"issue":"50","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1075","doi-asserted-by":"crossref","first-page":"52664","DOI":"10.1074\/jbc.M408108200","article-title":"Acute pH-dependent regulation of AE2-mediated anion exchange involves discrete local surfaces of the NH2-terminal cytoplasmic domain","volume":"279","author":"Stewart","year":"2004","journal-title":"J Biol Chem"},{"issue":"6 Pt 2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1080","first-page":"F1039","article-title":"AE anion exchanger mRNA and protein expression in vascular smooth muscle cells, aorta, and renal microvessels","volume":"273","author":"Brosius","year":"1997","journal-title":"Am J Phys"},{"issue":"7","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1085","first-page":"702","article-title":"Immunocytochemical analysis of band 3 protein in renal cell carcinoma, nephroblastoma, and oncocytoma","volume":"118","author":"Bonsib","year":"1994","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1090","first-page":"1565","article-title":"Different sequences of expression of band 3, spectrin, and ankyrin during normal erythropoiesis and erythroleukemia","volume":"142","author":"Nehls","year":"1993","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1095","first-page":"945","article-title":"Human erythroid band 3 \"anion exchanger 1\" is expressed in transformed lymphocytes","volume":"42","author":"Kay","year":"1996","journal-title":"Cell Mol Biol (Noisy-le-Grand)"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00428-009-0862-3","article-title":"Clinicopathologic characteristics of pleomorphic carcinoma of the breast","volume":"456","author":"Zhao","year":"2010","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0005-2736(89)90109-0","article-title":"Abnormalities in erythrocyte membrane band 3 in chronic myelogenous leukemia","volume":"985","author":"Kundu","year":"1989","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1110","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1002\/j.1460-2075.1992.tb05414.x","article-title":"Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukaemic phenotype","volume":"11","author":"Fuerstenberg","year":"1992","journal-title":"EMBO J"},{"issue":"3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1115","first-page":"539","article-title":"Erythrophagocytosis and its relation to band 3 clustering in chronic myelogenous leukemia","volume":"41","author":"Das","year":"1997","journal-title":"Biochem Mol Biol Int"},{"issue":"5","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1120","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.4049\/jimmunol.181.5.3674","article-title":"Chronic lymphocytic leukemia cells bind and present the erythrocyte protein band 3: possible role as initiators of autoimmune hemolytic anemia","volume":"181","author":"Galletti","year":"2008","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1125","doi-asserted-by":"crossref","first-page":"17921","DOI":"10.18632\/oncotarget.14900","article-title":"Expression and role of anion exchanger 1 in esophageal squamous cell carcinoma","volume":"8","author":"Shiozaki","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1130","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00432-009-0573-9","article-title":"Expression of anion exchanger 1 is associated with tumor progress in human gastric cancer","volume":"135","author":"Xu","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"issue":"10","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1135","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1593\/neo.07403","article-title":"Expression of anion exchanger 1 sequestrates p16 in the cytoplasm in gastric and colonic adenocarcinoma","volume":"9","author":"Shen","year":"2007","journal-title":"Neoplasia (New York)"},{"issue":"10","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1140","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.febslet.2005.02.063","article-title":"Direct interaction and cooperative role of tumor suppressor p16 with band 3 (AE1)","volume":"579","author":"Fu","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/B978-0-12-819059-3.00017-4_bb1145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.humpath.2018.07.020","article-title":"Ectopic expression of band 3 anion transport protein in colorectal cancer revealed in an autoimmune hemolytic anemia patient","volume":"83","author":"Kawamoto","year":"2019","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1150","first-page":"81","article-title":"Expression of anion exchanger 2 in human gastric cancer","volume":"30","author":"Yang","year":"2008","journal-title":"Exp Oncol"},{"issue":"5-6","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1155","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00439-009-0645-6","article-title":"Bladder cancer SNP panel predicts susceptibility and survival","volume":"125","author":"Andrew","year":"2009","journal-title":"Hum Genet"},{"issue":"3","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1152\/physiolgenomics.2001.5.3.119","article-title":"VHL tumor suppressor regulates Cl-\/HCO3- exchange and Na+\/H+ exchange activities in renal carcinoma cells","volume":"5","author":"Karumanchi","year":"2001","journal-title":"Physiol Genomics"},{"issue":"4","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1165","first-page":"192","article-title":"Overexpression of anion exchanger 2 in human hepatocellular carcinoma","volume":"49","author":"Wu","year":"2006","journal-title":"Chin J Physiol"},{"issue":"6","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1170","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00109-011-0851-2","article-title":"Gastrin inhibits a novel, pathological colon cancer signaling pathway involving EGR1, AE2, and P-ERK","volume":"90","author":"Song","year":"2012","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1175","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/febs.12058","article-title":"EGR1 is critical for gastrin-dependent upregulation of anion exchanger 2 in gastric cancer cells","volume":"280","author":"Wang","year":"2013","journal-title":"FEBS J"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1180","doi-asserted-by":"crossref","first-page":"6362","DOI":"10.1038\/s41598-017-06472-w","article-title":"Knockdown of anion exchanger 2 suppressed the growth of ovarian cancer cells via mTOR\/p70S6K1 signaling","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"issue":"40","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1185","doi-asserted-by":"crossref","first-page":"25993","DOI":"10.18632\/oncotarget.25417","article-title":"Anion exchanger 2 suppresses cellular movement and has prognostic significance in esophageal squamous cell carcinoma","volume":"9","author":"Shiozaki","year":"2018","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1190","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/ijc.25124","article-title":"Gastrin suppresses the interdependent expression of p16 and anion exchanger 1 favoring growth inhibition of gastric cancer cells","volume":"127","author":"Tian","year":"2010","journal-title":"Int J Cancer"},{"issue":"13","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1195","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/onc.2009.481","article-title":"Induction of anion exchanger-1 translation and its opposite roles in the carcinogenesis of gastric cancer cells and differentiation of K562 cells","volume":"29","author":"Wu","year":"2010","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1200","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1476-5381.2011.01521.x","article-title":"Anti-tumor effects of small interfering RNA targeting anion exchanger 1 in experimental gastric cancer","volume":"165","author":"Suo","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"1-2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11010-007-9619-y","article-title":"Anion exchanger inhibitor DIDS induces human poorly-differentiated malignant hepatocellular carcinoma HA22T cell apoptosis","volume":"308","author":"Liu","year":"2008","journal-title":"Mol Cell Biochem"},{"issue":"1-2","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1210","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11010-009-0051-3","article-title":"Reduction of anion exchanger 2 expression induces apoptosis of human hepatocellular carcinoma cells","volume":"327","author":"Hwang","year":"2009","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1215","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3324\/haematol.2017.175687","article-title":"Targeting the anion exchanger 2 with specific peptides as a new therapeutic approach in B lymphoid neoplasms","volume":"103","author":"Celay","year":"2018","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1220","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1139\/o98-082","article-title":"Differential inhibition of AE1 and AE2 anion exchangers by oxonol dyes and by novel polyaminosterol analogs of the shark antibiotic squalamine. Biochemistry and cell biology","volume":"76","author":"Alper","year":"1998","journal-title":"Biochim Biol Cell"},{"issue":"6261","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1225","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1126\/science.aaa4335","article-title":"Crystal structure of the anion exchanger domain of human erythrocyte band 3","volume":"350","author":"Arakawa","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/B978-0-12-819059-3.00017-4_bb1255","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: a therapeutic perspective","volume":"14","author":"Martinez-Outschoorn","year":"2017","journal-title":"Nat Rev Clin Oncol"}],"container-title":["An Innovative Approach to Understanding and Treating Cancer: Targeting pH"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128190593000174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128190593000174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T13:47:21Z","timestamp":1757684841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128190593000174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780128190593"],"references-count":257,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-819059-3.00017-4","relation":{},"subject":[],"published":{"date-parts":[[2020]]}}}